T lymphocytes recognize Ag as peptide fragments associated with MHC molecules on the surface of APC (1, 2). MHC class II molecules have the specialized capacity to present peptides generated from extracellular Ag which enter the cell by endocytosis (3, 4) . The resulting class II-peptide complexes, products of the endosomal-lysosomal processing pathway, are recognized by CD4 + T cells. In contrast, class I MHC molecules primarily present peptides derived from proteins with access to the cytosol and its resident proteolytic machinery. Resulting class I-peptide complexes are important in directing the immune response of CD8 + cytolytic T lymphocytes against viraUy infected cells.
It has become increasingly clear, however, that class II can efficiently bind and present peptides derived from proteins synthesized within the APC (5) (6) (7) (8) (9) (10) (11) (12) (13) . This suggests that, in the absence of receptor-mediated uptake of extracellular protein, internally synthesized proteins may be the principal source of class II peptides. Like typical extracellular Ag, intracellular Ag could potentially access the endocytic processing pathway by internalization from the plasma membrane, by secretion and pinocytosis, or by receptor-mediated endocytosis. Internal Ag might also access the endosomal/lysosomal pathway by direct sorting from the trans-Gol~ network (TGN) 1, by heat shock protein (HSP)-mediated uptake from the cytosol (14) , or by autophagy (15) . Although the extent to which class II displays peptides derived from internally synthesized proteins is becoming increasingly apparent, the mechanisms governing their presentation remain poorly defined. Our understanding of class II presentation is largely derived from studies involving exogenous protein Ag. Interestingly, these studies have implicated the likely importance of several protein cofactors in class II Ag presentation including the invariant chain (Ii) (16) , HSPs (17) , and an as yet undefined protein(s) encoded by genes within the MHC (18) . It is not known if the same protein cofactors will regulate the presentation of internal versus external Ag or if these cofactors will vary with cell type.
To examine the regulation of class II presentation of an intracellular Ag, we developed an experimental system in which a peptide processed from an MHC class I molecule (L a) is displayed by the murine class II molecule I-A d (19) . The I-Ad/L a peptide complex is recognized by a T cell hybridoma derived from the Ld-negative, BALB/c-H-2 am2 mouse. This system affords us the opportunity to examine presentation of a typical ubiquitous Ag which, under physiologic levels of expression, gains access to class II independently of an ongoing viral infection. Using recombinant DNA technology and cellular transfection techniques, we altered (a) subcellular localization of the class I target Ag; (b) lineage of the cell expressing both the target Ag and class II restriction element; and (c) expression of Ii within the APC, all parameters of potential relevance for Ag presentation and subject to variation in vivo. Collectively, our data suggest a pathway of endogenous dass II Ag presentation, distinct from both the dassicaUy described class I and II presentation pathways, which may function selectively in the APC of different lineages.
Materials and Methods
Animals. BALB/c mice were purchased from the Jackson Laboratory (Bar Harbor, ME). H-2 Ld-negative BALB/c-H-2 am2 (dm2) mice (20) were bred at the University of Chicago in a barrier facility from stock provided by Dr. Roger Melvold (Northwestern University, Chicago, IL).
Tissue Culture Reagents. Cell lines were maintained at 37~ and 5% COs in supplemented R.PMI as described (21) plus selection drugs G418 (0.2 mg/ml), MXFI (6/~g/ml mycophenolic acid, 0.3 mg/ml xanthine, and 15/~g/ml hypoxanthine) (Sigma Chemical Co., St. Louis, MO), and histidinol (5 mM) as indicated. All media and supplements were purchased from GIBCO BRL (Grand Island, NY) unless otherwise noted. The synthetic peptide corresponding to amino acids 61-85 of L d was synthesized at the University of Chicago Cancer Center. Chicken OVA and horse myoglobin (hMYO) were purchased from Sigma Chemical Co. and tryptic digests of each (OVAT and MYOT, respectively) were prepared as described by Shimonkevitz et al. (22) [30] ) was provided by D. Sachs (NIH), whereas F23.1 (anti-TCR Vfl8 [31] ) culture supematant was kindly provided byJ. Bluestone (University of Chicago). Ii-reactive mAbs (P4H5 [32] , IN-1 [33] ) were gifts fromJ. Miller (University of Chicago). The mAbs 2.43 (anti-CD8 [34] ) and GK1.5 (anti-CD4 [35] ) were provided by F. Fitch (University of Chicago). Antibodies were used as culture supernatants except for in vivo T cell depletion experiments where an ascites preparation of 2.43 was used.
Flow Cytometry. Cells were evaluated for MHC molecule cell surface expression using mAb as culture supernatants and a secondary staining reagent (FITC-labeled goat anti-mouse Ig [FITC-GAM]; Cappel Laboratories, Cochranville, PA) as described (21) , and analyzed on a FACScan | cytofluorimeter (Becton Dickinson & Co., Mountain View, CA). Background control fluorescence was measured using an irrelevant mAb plus FITC-GAM or medium alone and FITC-GAM (as indicated in each figure, see Results).
Gene Constructs. The L a genomic done pLa.4 was kindly provided by T. Hansen (Washington University, St. Louis, MO) and pLa/QIO (36) was provided by D. Margulies. An L d eDNA (37) was cloned into the Lk444 (38) vector utilizing the fl-actin promoter (pLd444), and a leaderless L a construct (pLa,~) was generated from pLa444 utilizing PCK mutagenesis to remove the sequence encoding the leader peptide from L d and then adding an initiation sequence (39) (44) by the calcium phosphate method yielding LAD-LD (MGT1) and LADgIi-LD (MGT2), respectively. Sublines were selected in MXH, G418, and histidinol. Transfectants matched for class II and L d expression were obtained by mAb and magnetic bead cell sorting. The EL4 cell line (ELAD) was subsequently supertransfected with genomic L a (pLa.4) and pSV2neo by electroporation, and the resulting cells (ELAD-LD) selected in G418 and MXH.
The embryonic cell line EE2H3 (H'2 k) originally derived by Silverman et al. (45) and provided by J. Bluestone was transfected with I-A a, genomic L d, and pSV2neo by the calcium phosphate method, EE2H3-ADLD transfectants (GEE.4) were selected in G418 and sorted for I-A a expression.
T Cell Lines and Hybridomas.
The CD4 + T cell clones 93.1 (bA d restricted, L a peptide 61-85 specific) and 50.13 (H-2L a restricted) were obtained from dm2 mice immunized with full thickness BALB/c skin grafts (19) . T cell clones were fused with the hypoxanthine guanine phosphoribosyl transferase (HGPRT) negative thymoma line or-fl-BW5147 by fusion with polyethylene glycol (PEG 1500; Boehringer Mannheim, Mannheim, Germany) (46) . Hybridomas were selected with HAT (GIBCO BILL) and plated at limiting dilution. Hybridomas from the 93.1 clone (GTH) were screened on irradiated (2,000 rad) BALB/c splenocytes and DAP-ADLD transfectants for their ability to produce lymphokines, whereas those from 50.13 (EM50.13) were screened on A20 and DAP-LD.
A CD4 +, Ld-reactive bulk T cell population was generated by immunization of CD8-depleted dm2 mice with irradiated BALB/c splenocytes. In vivo T cell depletion was performed as described (19) Coculture Assays. Irradiated dm2 or BALB/c splenocytes were incubated with La/QIO containing supernatant as described (see Fig. 3 legend) . Ceil'cell coculture experiments were performed in 25 cm 2 culture flasks using equal numbers of DAP-AD and DAP-LD/Q10, as indicated (see Fig. 3 legend) . L. Boyd and D. Margulies kindly provided us with purified Ld/Q10 and performed quantitative analysis of Ld/Q10 contained in supernatants from DAP-ADLD/Q10 and DAP-LD/Q10 cultures using an ELISA assay.
Metabolic Labeling~ Immunoprecipitation, and SDS-PAGE. Metabolic labeling and immunoprecipitation of proteins from transfected cells was performed as previously described (47) . Immunoprecipitated material was analyzed by SDS-10% PAGE. All SDS gels were treated with EN3HANCE (New England Nuclear, Boston, MA), dried, and autoradiographs prepared at -70°C.
Resulm
The T Cell Hybridoma GTH Maintains the Reactivity Pattern of the Parent T Cell Clone. We generated a T cell hybridoma from the clone 93.1 and ct-,/~-BW5147 (19) . The use of a hybridoma diminishes the contribution of accessory molecules to T cell stimulation and provides a more direct method of assessing peptide-MHC complex expression. by I-A d and specific for a fragment of L a, mirroring the reactivity of the parent dm2-derived T cell clone.
Cell Surface Expression of H-2L d Is Not Required for Processing and Presentation by I-A d. The most obvious route for
an endogenously synthesized transmembrane Ag to gain access to the endocytic processing compartment is by internalization from the plasma membrane. To determine whether cell surface expression of L a is required for processing and presentation of the L d peptide, a gene encoding a soluble form of the target Ag (La/Q10) was transfected into DAP.3 with or without the I-A a restriction element. Ld/Q10 (comprised of the NH~-terminal or1 and c~2 domains of L a and the c~3 COOH-terminal domain of Q10 [36] ) associates with B2 microglobin, maintains normal ctl and a2 antibody epitopes, lacks a transmembrane domain, and is thus not expressed at the cell surface, but is secreted into the extracellular medium. Fig. 2 A shows metabolically labeled La/Q10 precipitated from whole L cell transfectant lysates (lane 3) or from the extracellular medium (lane 9). As expected, Ld/Q10 was not detected at the cell surface by immunofluorescence staining (Fig. 3 D) , nor was an La-restricted alloreactive T cell hybridoma (EM50.13) stimulated by Ld/Q10 transfectants (data not shown). Despite a lack of L d surface expression, DAP-ADLD/Q10 transfectants processed and presented the target L a peptide to GTH as effectively as DAP-ADLD (Fig. 2 B) .
To varying domain specificity and increasing antibody incubation times, no specific modulation of L d Ag presentation was detected for either DAP-ADLD or DAP-ADLD/Q10 (data not shown).
Presentation of the Secreted Ld/QIO Does Not Occur by Internalization from the Medium.
To test the possibility that secreted Ld/Q10 enters the class II Ag processing compartment by reuptake from the extracdlular medium, DAP-AD cells were incubated for 4 d, or irradiated din2 splenocytes (spin) were incubated overnight, with supernatant (SN) containing La/Q10. Neither DAP-AD nor dm2 splenocytes stimulated GTH when pulsed with Ld/Q10 (Fig. 3, A and   B ). The La/QlO-contfLffmg supernatant used in these experiments was freshly obtained from confluent flasks containing DAP-ADLD/Q10 transfectants, and cells from these same flasks were effective stimulators of GTH (Fig. 3, A and B, shaded bars). Moreover, purified La/Q10 added to DAP-AD at a concentration 1,000-fold higher than that maximally accumulated in the medium of Ld/Q10-secreting cells did not stimulate GTH (Fig. 3 E) . To test whether suboptimal levels of peptide-MHC complexes were expressed by DAP-AD in the presence of purified soluble Ld/Q10, we performed a dose-response assay using synthetic L a 61-85 peptide. We reasoned that if a significant but subthreshold level of processed L d peptide was displayed in the presence of high-dose Ld/Q10, then less L d 61-85 peptide should be required to stimulate GTH. This should result in a shift to the left in the L d 61-85 peptide dose-response curve. No such shift in the peptide dose-response curve was evident in the presence of exogenously added soluble Ld/Q10 (Fig. 3 E, 9 vs D). These results strongly suggest that the epitope recognized by GTH is not readily generated after endocytosis of target Ag from the culture medium.
Although exposure of APC to extracellular La/Q10 did not result in detectable levels of GTH-specific peptide, we considered the possibility that cell-ceU contact might facilitate Ld/Q10 uptake. To address this possibility, cells transfected with La/Q10 alone (DAP-LD/Q10) were cocultured with DAP-AD. APC from these mixed cultures did not stimulate GTH, indicating that presentation of the determinant recognized by GTH does not occur by uptake of La/Q10 from the medium or from adjacent cells (Fig. 3 B, open bar) .
To test whether the secreted L a Ag could serve as substrate for the generation of peptide epitopes other than that recognized by GTH, we generated a polyclonal dm2 anti-BALB/c CD4 + T cell population. As shown in Fig. 3 C, CD4 § T cells obtained from immunized dm2 mice were able to recognize and proliferate in response to I-Aa-bearing APC cocultured with either DAP-LD/Q10 cells or supernatant containing La/Q10. This suggests that a recognizable epitope(s) is generated from Ld/Q10 after endocytosis, and that this epitope is likely distinct from that generated from internally synthesized Ld/Q10.
In summary, our results using the Ld/Q10 construct indicate that cell surface expression of the target Ag is not required, nor is addition of the target Ag to the extraceUular medium sufticient, for generation of peptide-class II complexes recognized by GTH. This suggests that the L a peptide is generated during intracellular biosynthesis and transport of the newly synthesized target Ag. Thus, internally derived L d either accesses the class II endosomal processing compartment with far greater efticiency than exogenous Ag, or it employs proteolytic machinery different from that used to process extracellular Ag taken up by endocytosis.
A Cell Line Deficient in Presentation of Exogenous Nominal Ag Efl;ciently Presents the Endogenously Derived L d Peptide.
To explore the possibility that L d and exogenous Ag utilize distinct presentation pathways, we examined a cell deficient in exogenous Ag presentation for its ability to process and present Fig. 4 A demonstrates the inability of ELAD to stimulate the hMYO-specific, I-Ad-restricted T cell hybridoma ACHhMyo/27.7 in the presence of whole hMyo Ag. In the presence of MYOT, however, ELAD stimulated ACHhMyo/27.7 as effectively as DAP-AD (Fig. 4 B) . We also found ELAD incapable of presenting exogenous nominal 77 Loss et al. peptide dose-response curves were generated in the presence or absence of exogenously added soluble La/Q10 (Fig. 5 D,  9 vs [2] ). Thus, we conclude that ELAD are deficient in the presentation of nominal Ag including exogenously provided La/Q10. To determine if ELAD can process and present internally derived L d peptide, ELAD cells were supertransfected with the gene encoding L a (ELAD-LD) and tested for their ability to stimulate GTH. As shown in Fig. 5 C, these cells efficiently stimulated GTH suggesting that events critical for class II presentation of internally synthesized L a are fundamentally different from those critical for class II presentation of exogenous Ag. A similar conclusion was recently reached by Bikoff (49) using this cell line.
We considered several possibilities to explain this result. First, staining profiles for ELAD-LD and DAP-ADLD using several anti-I-A a and anti-L d mAbs (Fig. 5 A) demonstrate that the two APC have comparable expression of both the restriction dement and the target Ag. Second, it was possible that ELAD effectively presented L a because of an enhanced avidity of ELAD for the GTH hybridoma. But when Ag processing is bypassed through addition of synthetic L d 61-85 peptide, ELAD and DAP-AD are nearly equivalent APC for GTH (Fig. 5 B) . Finally, we considered the possibility that stimulation of GTH occurred because of supersaturating amounts of L a peptide generated by the internal route of presentation. This excess would allow ELAD-LD to display peptides derived from internal L a at threshold levels for T cell stimulation compared to subthreshold levels from peptides derived from exogenous Ag. To more accurately quantify the efficiency of presentation, Ag presentation blocking experiments were performed using varying concentrations of anti-I-A d (M5114) mAb added to ELAD-LD or to control DAP-ADLD APC (Fig. 5 F) . Parallel blocking studies were performed in Ld-negative DAP-AD and ELAD cells using the L a 61-85 peptide (Fig. 5 E) to control for the adhesion/accessory properties of these APC. Antibody concentrations capable of effecting a 50% reduction in the maximal GTH response were then calculated for each APC. Based on these assays, we conclude that ELAD-LD processing and presentation of internally derived L a is in fact approximately threefold more efficient than DAP-ADLD (Fig. 5, E and F) . These data argue against the possibility that EL4 transfectants present internal L d Ag, but not exogenous Ag, because endogenous Ag gain access to the dass II presentation pathway more efficiently than exogenous Ag. These results, therefore, support our hypothesis that the L a peptide is generated by intracellular processing events that may differ from those typically used to process exogenous Ag.
Pancreatic Islet Cells Fail to Present Internally Synthesized L d.
Our experiments using EL4 suggest that presentation of exogenous Ag by MHC class II is not a ubiquitous activity shared by all APC. We therefore examined a large pand of cells for the ability to present the L d to GTH to evaluate whether presentation of internally synthesized Ag is an activity universally shared by APC. One cell line tested, a pancreatic islet cell line (/3TC-3 [H-2d]) (43) transfected with I-A a (B-AD), can be induced to express high levels of MHC molecules upon treatment with IFN-'y and TNF (50, 51) . The I-A a islet transfectant was grown for 5 d in the presence or absence of 10 U/ml IFN-3~ and 100 U/ml TNF and stained with mAbs reactive with L a and I-A d. Fig. 6 A shows that in untreated cells (M), the L a surface staining is only slightly above background levels obtained with an irrelevant control mAb. In contrast, when cells are grown in the presence of cytokine, H-2L d expression increases lO-20-fold. High levels of L a surface expression were detected with both peptide-dependent (30-5-7) and -independent (28-14-8) anti-L a mAb (Fig. 6 A and data not shown) suggesting that the MHC class I presentation pathway is functional in the cytokine-treated cells. (Fig. 6 B) (Fig. 6 B) . Nor was a shift in the L d 61-85 peptide dose-response curve observed after induction of L a expression (Fig. 6 B) . Control experiments demonstrated that TNF and IFN-3~ treatment had no effect on/~-AD exogenous Ag presentation (Fig. 6, C and D) and did not antagonize exogenous or endogenous Ag presentation in control APC (Fig. 6, E-H) . From these experiments, we conclude that expression of endogenous L a within the default exocytic pathway and at the cell surface is insufficient for presentation of the target peptide to GTH. Rather, these data suggest that presentation of internally synthesized Ag by class II requires protein cofactors in addition to MHC class II, and that these cofactors may be differentially expressed in different cell types. (Fig. 7 A) . In addition, peptide dose-response curves for DAP-AD and DAP-ADLDcyt were virtually identical (Fig. 7 B) suggesting no appreciable presentation of the cytoplasmic L a target Ag. The inability of Lay to gain access to the appropriate processing compartment indicates that cytosolic subsets of Ld/Q10 or wild-type L a that fail to translocate normally into the ER are unlikely to serve as precursors for the processed peptide recognized 
Untreated islet cells (/3-AD [M]) did not stimulate GTH

Expression of a Leaderless Form of the Target Ag Does Not
Ii Expression Has No Effect on Presentation of L a Peptide and Stimulation of GTH.
To test our second prediction, we examined the effect of Ii on Ag presentation. As a subset of L a is poorly transported out of the ER (53), it seemed plansible that resident ER proteolytic machinery (54) might process L a and generate peptides capable of binding newly synthesized class II molecules within the ER. Because experiments performed in vitro have demonstrated that Ii inhibits peptide binding to class II (16, 55, 56) , we reasoned that ER presentation should be blocked in APC which express high levels of Ii (Fig. 8 A) . We therefore examined L a peptide presentation by Ltk-APC transfected with b A d and L a with and without genomic Ii (LADgIi and LAD, respectively). As shown in Fig. 8 C, the Ii-positive and -negative APC stimulated G T H similarly, indicating that Ag presentation of L d is independent of Ii expression.
A Cell Line Deficient in Class 1-restricted Ag Presentation Presents the Internally Synthesized L d by MHC Class II.
To address whether L a presentation is dependent on the functional TAP proteins which are important for class I Ag presentation, we examined the ability of a cell line deficient in M H C class I assembly (EE2H3) to stimulate G T H . EE2H3 is an H-2 k embryonic cell line that is d~g~t in the expression of the putative peptide transporter TAP-1 and has a pheno- type resembling that of RMA-S (45, 57) . EE2H3 was transfected with genes encoding L a and bA d and the resulting transfectants (EE2H3-ADLD) tested for the ability to stimulate GTH. As shown in Fig. 9 , EE2H3-ADLD effectively stimulated GTH despite near background levels of L d surface staining. In conjunction with the results described above, these data suggest that class II-restricted presentation of L d to GTH may not follow typical class I or II presentation pathways.
Discunion
Class II molecules are specialized to present peptides derived from exogenous Ag but are also capable of presenting peptides derived from proteins synthesized within the APC. Most of the studies addressing the mechanisms of class II Ag presentation have focused on the former (58, 59) . These studies, in conjunction with those examining class II trafficking (60) (61) (62) , the relationship between class II and Ii (16, 42, 55, 56) , and the formation of stable class II dimers (63) , have led to the general model that class II binds to peptides derived from Ag that enter the APC by endocytosis and are proteolyzed within acidic vesicles of the endosomal/lysosomal pathway. Clearly, internally synthesized secretory or integral membrane proteins theoretically have access to the putative endosomal/lysosomal processing pathway. However, it is becoming increasingly dear that internal Ag may access endosomes/lysosomes by mechanisms other than endocytosis, including chaperone-mediated trafficking from the cytosol, autophagy from the cytosol and ER, and direct trafficking from the TGN. It is less clear whether the route by which an Ag enters the endosomal/lysosomal pathway affects the repertoire of peptides revealed (64), or if different routes employ different processing cofactors. For example, prolonged Ag expression within the ER or Ag interaction with HSPs might influence processing such that the dominant epitopes generated are different from those revealed after endocytosis from the extracellular fluid.
We have established a model system designed to examine the mechanisms governing MHC class II presentation of an endogenous Ag. Unique to our system is the use of a target Ag (MHC class I, L d) that is constitutively expressed by a variety of nucleated cells, providing us with the opportunity to study the processing requirements for a normally expressed protein in cells of different lineages. T cells recognizing this epitope are stimulated by unmanipulated BALB/c splenocytes indicating that this peptide-class II complex is not only one which APC can be designed to generate, but is also one which is naturally displayed in vivo.
One possible explanation for the presentation of internally derived surface proteins by class II is that these proteins gain access to the endocytic pathway by internalization from the cell membrane. Using a secreted form of L d, we demonstrated that surface expression is not essential for L d presentation. Experiments using purified soluble Ld/Q10 demonstrated that GTH was not stimulated even at Ag concentrations 1,000-fold greater than those present in the culture medium of DAP-ADLD/Q10 transfectants. Moreover, dm2 splenocytes, which include cells considered to be professional APC, were unable to present the exogenously added soluble form of L d. These results, coupled with those obtained in a series of coculture experiments, suggest that the secreted target Ag does not gain access to the class II presentation pathway by uptake from the extraceUular milieu. We are confident that effective stimulators of GTH within 2 d of transfection (data not shown). The finding that soluble La/Q10 added to I-Aa-bearing APC resulted in the stimulation of a bulk population of CD4 + anti-BALB/c T cells demonstrates that peptide determinants other than those recognized by GTH were generated from Ld/Q10. Attempts to modulate L a processing and presentation with exogenously added anti-L d antibody proved ineffective using APC expressing either the cell surface form of L d or the secreted La/Q10 (data not shown). This is consistent with our hypothesis that a cell surface or extracellular intermediate is not involved in generating the L d peptide recognized by GTH. Moreover EL4, a cell line defective in exogenous Ag presentation, effectively processed and presented internally synthesized L d. Taken together, these data support the hypothesis that processing of L a resulting in the peptide recognized by GTH takes place during biogenesis and intracellular transport of the target Ag.
Our experiments also address whether the L a target Ag accesses dass I proteolytic machinery within the cytosol. Tramfection of APC with a cytosolic form of L d did not result in stimulation of GTH. This is consistent with class II-restricted endogenous Ag presentation systems reported by Brooks et al. (10) and Weiss and Bogen (7), although several studies have indicated that cytosolic proteins may gain access to class II if they are expressed at very high levels (6, 8) . Attempts to augment expression of La~yt by increasing gene copy number in a transient transfection assay or by regulating expression with the strong ~-actin promoter did not result in stimulation of GTH, nor was Ld~ presentation revealed by subjecting APC to serum starvation or heat shock (data not shown). These results suggest it is unlikely that improperly translocated L a plays any role in stimulation of GTH. In support of this conclusion, transfectants of EE2H3 (45, 57), a cell line deficient in class I Ag presentation, effectively stimulated GTH. Finally, using three different cell types, we have found that Ii fails to block class II-restricted presentation of L d. It is therefore improbable that the classical class I processing pathway generates the L a peptide recognized by GTH.
One of the most intriguing results from this series of experiments relates to the differences observed between different cell types in exogenous and endogenous Ag presentation. A lymphobhst tumor cell line (EL4) defective in exogenous class II Ag presentation effectively stimulated GTH. In contrast, a pancreatic cell line (BTC-3) capable of exogenous Ag presentation, was unable to present endogenous L a despite high surface expression of both the restriction element and the L a target Ag. These results suggest that to generate and present the L a peptide, it is insuffident to merely express the target Ag and the appropriate MHC class II restriction element. Taken together, our results suggest that different cofactors may regulate endogenous and exogenous class II Ag presentation and that expression of these cofactors may be regulated in a tissue-specific manner. This possibility is consistent with earlier work showing that some APC, differing in cell type or physiologic state, show differences in their ability to present epitopes derived from extracellular Ag (65, 66) . Although the biological basis for the observed differences remains to be determined, our observations suggesting that different cell lines process and present Ag differently have potential implications for a number of immune phenomena including thymic selection, where different APC types are believed to be responsible for positive and negative selection, and autoimmune responses, where tissue-specific Ag presentation might play a role in the pathogenesis of localized, T cell-mediated autoimmune disease.
